Ford India starts production of face shields at plants in Sanand, Chennai; to be distributed to healthcare workers, emergency staff
The protective face shield is designed and developed by Ford engineers and will be distributed to frontline workers.
New Delhi: Auto maker Ford India on Tuesday said it is manufacturing face shields at its manufacturing plants which would be distributed among doctors, paramedics and emergency staff.
The maker of models like Endeavour and EcoSport said it has come up with a team at its manufacturing plants at Sanand and Chennai to produce face shields.
The protective face shield is designed and developed by Ford engineers and will be distributed to frontline workers – doctors, paramedics, sanitary workers and emergency staff, Ford India said in a statement.
Alongside its commitment to contribute to Prime Minister National Relief Fund (PMNRF), the company is following up with a global COVID-19 Donation Match programme to raise $1 million potential aid for groups battling the pandemic across the globe, it added.
Through the COVID-19 Donation Match, Ford Fund is giving employees, as well as their families and friends, an opportunity to donate to non-profits and other community organisations in their efforts to meet coronavirus -related needs in more than 20 countries around the world.
In India, the initiative will take care of specially-abled communities during the time of crisis, it said.
“Health and safety of our workforce, customers and communities is our highest priority. From knowledge to resources, we are deploying everything in our means to help fight this pandemic,” Ford India executive director marketing, sales and Service Vinay Raina said.
The company has also rolled out initiatives for its customers, like price protection for vehicles booked until April 30, warranty extension and extension of service timelines.
'Come together to defeat BJP': Mamata Banerjee discusses Oppn unity, Pegasus row with Sonia and Rahul
Banerjee's visit during the ongoing Parliament's Monsoon Session assumes increased significance with the Opposition cornering the Centre on price rise, increasing cost of fuel and COVID-19 pandemic
It said that more than 45.37 crore vaccine doses have been provided to states and UTs so far through all sources and a further 59,39,010 doses are in the pipeline
COVID-19 vaccine production increasing, India may be first country to have DNA-based jab, Mansukh Mandaviya tells RS
Replying to a short discussion on COVID-19 management in Rajya Sabha, the minister said technology transfer to several companies has started and they will begin production in the coming days